照護現場診斷市場規模、佔有率、成長分析（按產品、採購類型、技術、樣本、最終用戶和地區）- 2025 年至 2032 年產業預測

2023 年全球照護現場診斷市場規模為 451 億美元，預計將從 2024 年的 492.9 億美元成長到 2032 年的 1,004.1 億美元，預測期內（2025-2032 年）的複合年成長率為 9.3%。

受 POC 設備技術進步、感染疾病激增以及主要企業的投資增加所推動，照護現場診斷 (POC) 市場正在經歷強勁成長。由於結核病、愛滋病等感染疾病急劇上升，且患者需要立即知道檢測結果，因此市場正在不斷擴大。這一趨勢凸顯了醫療保健產業對更多以患者為中心的設備和解決方案的追求。微射流和微製造領域的創新使得 POC 診斷更便宜、更易於使用、更便攜、更有效率，徹底改變了患者照護。公司正在投入越來越多的資源用於旨在增強微流體技術的研究，進一步推動發展並有望改善患者的治療效果。總體而言，POC 診斷領域正在繼續顯著發展，以滿足醫療保健提供者和患者的需求。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 專利分析
• 監管分析
• 技術分析
• 使用案例
• 客戶和購買標準分析

照護現場診斷市場規模（依產品分類）及複合年成長率（2025-2032）

• 市場概覽
• 血糖值監測產品
  • 血糖監測試紙
  • 血糖監測儀
  • 血糖監測採血採血針及採血裝置
• 心臟代謝監測產品
  • 心臟標記檢測產品
  • 血氣/電解質檢測產品
  • HBA1C 測試產品
• 傳染病檢查產品
  • 呼吸道傳染病檢查產品
  • 醫療保健相關感染檢測產品
  • 熱帶疾病檢測產品
  • 性行為感染傳染病檢測產品
• 凝血監測產品
  • PT/INR 測試產品
  • ACT/APTT檢測產品
• 妊娠及不孕症檢測產品
• 腫瘤/癌症標記檢測產品
• 尿液檢查產品
• 膽固醇檢測產品
• 血液檢測產品
• 藥物濫用檢測產品
• 甲狀腺刺激素檢測產品
• 大便潛血試驗產品
• 其他

按購買類型和複合年成長率分類的照護現場診斷市場規模（2025-2032 年）

• 市場概覽
• 處方藥檢測產品
• 非處方藥物檢測產品

依技術分類的照護現場診斷市場規模及複合年成長率（2025-2032）

• 市場概覽
• 生物化學
• 免疫檢測
• 分子診斷
  • RT-PCR
  • INAAT

以樣本類型和複合年成長率分類的照護現場診斷市場規模（2025-2032）

• 市場概覽
• 血液樣本
• 鼻腔和口咽拭子
• 尿液樣本
• 其他樣品

依最終用戶照護現場診斷市場規模及複合年成長率（2025-2032）

• 市場概覽
• 居家照護環境與自我檢測
• 臨床實驗室
• 醫院、急診和重症監護中心
• 門診護理設施和醫生診所
• 其他

照護現場診斷市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

    主要企業簡介

    • 雅培實驗室（美國）
    • 西門子醫療股份公司（德國）
    • Quidel公司（美國）
    • F. Hoffman-La Roche Ltd.（瑞士）
    • 丹納赫公司（美國）
    • 碧迪公司（美國）
    • Chembio Diagnostics（美國）
    • EKF診斷（英國）
    • Trinity BIoTech plc（愛爾蘭）
    • 儀器實驗室（美國）
    • PTS診斷公司（美國）
    • 積水診斷（美國）

結論和建議

Global Point Of Care Diagnostics Market size was valued at USD 45.1 billion in 2023 and is poised to grow from USD 49.29 billion in 2024 to USD 100.41 billion by 2032, growing at a CAGR of 9.3% during the forecast period (2025-2032).

The point of care (POC) diagnostics market is witnessing robust growth driven by technological advancements in POC devices, a surge in infectious diseases, and heightened investments from leading companies. The escalating prevalence of conditions such as tuberculosis and AIDS, alongside patients' demand for immediate test results, fuels market expansion. This trend underscores the healthcare sector's push for more patient-centric devices and solutions. With innovations in microfluidics and microfabrication, POC diagnostics have become more affordable, user-friendly, portable, and efficient, revolutionizing patient care. Companies are increasingly channeling resources into research aimed at enhancing microfluidic technology, promising improved outcomes for patients and further propelling market development. Overall, the POC diagnostics landscape continues to evolve significantly, meeting the needs of healthcare providers and patients alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Point Of Care Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Point Of Care Diagnostics Market Segments Analysis

Global Point Of Care Diagnostics Market is segmented by Product, Mode Of Purchase, Technology, Sample, End User and region. Based on Product, the market is segmented into Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-Of-Abuse Testing Products, Thyroid-Stimulating Hormone Testing Products, Fecal Occult Testing Products and Other Products. Based on Mode Of Purchase, the market is segmented into Prescription-Based Testing Products and OTC Testing Products. Based on Technology, the market is segmented into Biochemistry, Immunoassays and Molecular Diagnostics. Based on Sample, the market is segmented into Blood Samples, Nasal & Oropharyngeal Swabs, Urine Samples and Other Samples. Based on End User, the market is segmented into Home Care Settings and Self-Testing, Clinical Laboratories, Hospitals, Critical Care Centers, and Urgent Care Centers, Ambulatory Care Facilities and Physician Offices and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Point Of Care Diagnostics Market

The Global Point of Care Diagnostics market is significantly propelled by ongoing technological advancements that aim to improve the usability of diagnostic devices. These innovations enhance the functionality and efficiency of point-of-care testing, allowing for quicker and more accurate results. As healthcare providers increasingly seek reliable and user-friendly solutions, the integration of cutting-edge technologies such as artificial intelligence, mobile connectivity, and portable testing equipment becomes crucial. This focus on enhancing usability not only facilitates better patient outcomes but also streamlines workflows in various clinical settings, driving the demand for advanced diagnostic tools in the global market.

Restraints in the Global Point Of Care Diagnostics Market

One of the significant restraints of the global point-of-care diagnostics market is the high initial investment costs associated with the development and implementation of diagnostic technologies. These expenses can pose a barrier for healthcare providers, particularly smaller facilities or those in developing regions, limiting their ability to adopt advanced diagnostic solutions. Additionally, the financial burden can deter investment in new technologies, hindering innovation and slowing the overall growth of the market. As a result, addressing these high upfront costs is crucial for enhancing the accessibility and widespread utilization of point-of-care diagnostic services worldwide.

Market Trends of the Global Point Of Care Diagnostics Market

The Global Point Of Care Diagnostics market is witnessing significant growth driven by advancements in personalized medicine. As healthcare shifts towards individualized treatment approaches, the demand for rapid, accurate diagnostics at the point of care is on the rise. Innovative technologies, such as portable devices and microfluidics, enable healthcare professionals to deliver real-time, tailored testing results that enhance patient outcomes. Moreover, integration with digital health platforms and data analytics is streamlining the diagnostic process, fostering greater accessibility and efficiency. As a result, stakeholders are increasingly investing in point-of-care solutions to meet the evolving needs of personalized healthcare, positioning the market for robust expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies
• Customer And Buying Criteria Analysis

Global Point Of Care Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Glucose Monitoring Products
  • Glucose Monitoring Strips
  • Glucose Monitoring Meters
  • Glucose Monitoring Lancets & Lancing Devices
• Cardiometabolic Monitoring Products
  • Cardiac Marker Testing Products
  • Blood Gas/Electrolyte Testing Products
  • HBA1C Testing Products
• Infectious Disease Testing Products
  • Respiratory Infection Testing Products
  • Healthcare-Associated Infection Testing Products
  • Tropical Disease Testing Products
  • Sexually Transmitted Disease Testing Products
• Coagulation Monitoring Products
  • PT/INR Testing Products
  • ACT/APTT Testing Products
• Pregnancy & Fertility Testing Products
• Tumor/Cancer Marker Testing Products
• Urinalysis Testing Products
• Cholesterol Testing Products
• Hematology Testing Products
• Drugs-Of-Abuse Testing Products
• Thyroid-Stimulating Hormone Testing Products
• Fecal Occult Testing Products
• Other Products

Global Point Of Care Diagnostics Market Size by Mode Of Purchase & CAGR (2025-2032)

• Market Overview
• Prescription-Based Testing Products
• OTC Testing Products

Global Point Of Care Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Biochemistry
• Immunoassays
• Molecular Diagnostics
  • RT-PCR
  • INAAT

Global Point Of Care Diagnostics Market Size by Sample & CAGR (2025-2032)

• Market Overview
• Blood Samples
• Nasal & Oropharyngeal Swabs
• Urine Samples
• Other Samples

Global Point Of Care Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Home Care Settings and Self-Testing
• Clinical Laboratories
• Hospitals, Critical Care Centers, and Urgent Care Centers
• Ambulatory Care Facilities and Physician Offices
• Other End Users

Global Point Of Care Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Mode Of Purchase, Technology, Sample, End User)
  • US
  • Canada
• Europe (Product, Mode Of Purchase, Technology, Sample, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Mode Of Purchase, Technology, Sample, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Mode Of Purchase, Technology, Sample, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Mode Of Purchase, Technology, Sample, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffman-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chembio Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Instrumentation Laboratory (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTS Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations